We acquired Skylight Biotech Inc.and established Neosilk Cosmetics Co., Ltd. in 2013. We have made efforts to enhance the synergy of the IBL-group and achieve our goals through our four core businesses (Diagnostic and Research Reagent Business, Transgenic Silkworm-based Protein Production Business, Testing Service, and Cosmetic Business).
We provide research reagents and materials for in-vitro diagnostic products, and license our antibodies to researchers who conduct research in the fields with unmet medical needs.
We aim to supply various high-quality proteins, including antibodies produced from cocoons using transgenic silkworms, at reasonable prices to vaccine makers, pharmaceutical companies and manufactures of diagnostic products.
Equity Method Affiliate
Cured Co., Ltd.